TLRY
Tilray Inc
NASDAQ: TLRY · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$2.64
-1.86% today
Updated 2026-10-29
Market cap
$409.37M
P/E ratio
—
P/S ratio
0.43x
EPS (TTM)
$-1.41
Dividend yield
—
52W range
$3 – $16
Volume
4.0M
Tilray Inc (TLRY) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$2.64
12-Month target
—
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.6B | $0.8B | $1.1B | $0.8B | $0.9B | $1.0B | $1.2B | $1.3B | $1.5B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: 12.28% (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -17.10%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.